| Title : Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009-05 study - Martin_2011_J.Clin.Oncol_29_1008 |
| Author(s) : Martin M , Martinez N , Ramos M , Calvo L , Lluch A , Zamora P , Munoz-Mateu M , Caronia D , Carrasco EM , Garcia Saenz JA , Casado A , Chacon I , Hernando B , Ruiz-Borrego M , Gonzalez-Neira A |
| Ref : J Clin Oncol , 29 :1008 , 2011 |
| Abstract : Martin_2011_J.Clin.Oncol_29_1008 |
| ESTHER : Martin_2011_J.Clin.Oncol_29_1008 |
| PubMedSearch : Martin_2011_J.Clin.Oncol_29_1008 |
| PubMedID: 28020778 |
Martin M, Martinez N, Ramos M, Calvo L, Lluch A, Zamora P, Munoz-Mateu M, Caronia D, Carrasco EM, Garcia Saenz JA, Casado A, Chacon I, Hernando B, Ruiz-Borrego M, Gonzalez-Neira A (2011)
Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009-05 study
J Clin Oncol
29 :1008
Martin M, Martinez N, Ramos M, Calvo L, Lluch A, Zamora P, Munoz-Mateu M, Caronia D, Carrasco EM, Garcia Saenz JA, Casado A, Chacon I, Hernando B, Ruiz-Borrego M, Gonzalez-Neira A (2011)
J Clin Oncol
29 :1008